Skip to content

BLACK DIAMOND THERAPEUTICS, INC.

BDTX

CIK 0001701541

← back to feed
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
$28.45M
+132.1% YoY Q1 May 2026
EPS Diluted (TTM)
$0.48
+130.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
$1.9M
Q1 May 2026
Cash
$30.07M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
57.3M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings